Lawsuit Overview
An VRX investor filed a lawsuit in California Court on behalf of current investors Valeant Pharmaceuticals International (NYSE:VRX) alleging breaches of fiduciary duty by certain members of the Valeant Pharmaceuticals board of directors in connection with the takeover attempt by Biovail. According to the complaint the plaintiff alleges, among other things, that the proposed transacti...
You must register (for free) or login to view the entire case.